Gene · 10857
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Steroid profile in patients with breast cancer and in mice treated with mifepristone. | Endocr Relat Cancer | 2024 | 37962553 | PubTator, text mining | PubMed |
| Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease. | Front Immunol | 2023 | 38162644 | PubTator, text mining | PubMed |
| Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies. | Cancers (Basel) | 2023 | 38136274 | PubTator, text mining | PubMed |
| Reproductive health in Turner's syndrome: from puberty to pregnancy. | Front Endocrinol (Lausanne) | 2023 | 38116311 | PubTator, text mining | PubMed |
| Online COVID-19 diagnosis prediction using complete blood count: an innovative tool for public health. | BMC Public Health | 2023 | 38114942 | PubTator, text mining | PubMed |
| Performance Test of a Well-Trained Model for Meningioma Segmentation in Health Care Centers: Secondary Analysis Based on Four Retrospective Multicenter Data Sets. | J Med Internet Res | 2023 | 38100181 | PubTator, text mining | PubMed |
| Colorectal Cancer Immunotherapy: State of the Art and Future Directions. | Gastro Hep Adv | 2023 | 38098742 | PubTator, text mining | PubMed |
| Therapeutic cancer vaccines: advancements, challenges, and prospects. | Signal Transduct Target Ther | 2023 | 38086815 | PubTator, text mining | PubMed |
| [Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC]. | Zhongguo Fei Ai Za Zhi | 2023 | 38061884 | PubTator, text mining | PubMed |
| A Systems Biology Approach for Investigating Significant Biomarkers and Drug Targets Common Among Patients with Gonorrhea, Chlamydia, and Prostate Cancer: A Pilot Study. | Bioinform Biol Insights | 2023 | 38033384 | PubTator, text mining | PubMed |
| The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma. | Front Immunol | 2023 | 38022559 | PubTator, text mining | PubMed |
| Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions. | Front Aging Neurosci | 2023 | 38020773 | PubTator, text mining | PubMed |
| New insights on the potential effect of progesterone in Covid-19: Anti-inflammatory and immunosuppressive effects. | Immun Inflamm Dis | 2023 | 38018575 | PubTator, text mining | PubMed |
| Gene expression profiles separate endometriosis lesion subtypes and indicate a sensitivity of endometrioma to estrogen suppressive treatments through elevated ESR2 expression. | BMC Med | 2023 | 37996888 | PubTator, text mining | PubMed |
| PILLAR: ParaspInaL muscLe segmentAtion pRoject - a comprehensive online resource to guide manual segmentation of paraspinal muscles from magnetic resonance imaging. | BMC Musculoskelet Disord | 2023 | 37996857 | PubTator, text mining | PubMed |
| Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients' blood. | Cell Rep Med | 2023 | 37992683 | PubTator, text mining | PubMed |
| Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues. | Pharmacol Res Perspect | 2023 | 37983911 | PubTator, text mining | PubMed |
| Erectile dysfunction: role of computed tomography cavernosography in the diagnosis and treatment planning of venous leak. | CVIR Endovasc | 2023 | 37975993 | PubTator, text mining | PubMed |
| Regulatory action of PGRMC1 on cyclic AMP-mediated COX2 expression in human endometrial cells. | J Pharmacol Sci | 2023 | 37973216 | PubTator, text mining | PubMed |
| Structural determinants specific for retromer protein sorting nexin 5 in regulating subcellular retrograde membrane trafficking. | J Biomed Res | 2023 | 37964759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10857/papers?page=6